GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Creative Medical Technology Holdings Inc (NAS:CELZ) » Definitions » Cash Ratio

Creative Medical Technology Holdings (Creative Medical Technology Holdings) Cash Ratio : 26.92 (As of Dec. 2023)


View and export this data going back to 2009. Start your Free Trial

What is Creative Medical Technology Holdings Cash Ratio?

The Cash Ratio measures a company’s ability to meet its short-term obligations with cash and near-cash resources. It is calculated as a company's Cash, Cash Equivalents, Marketable Securities divides by its Total Current Liabilities. Creative Medical Technology Holdings's Cash Ratio for the quarter that ended in Dec. 2023 was 26.92.

Creative Medical Technology Holdings has a Cash Ratio of 26.92. It generally indicates that the company is able to cover all short-term debt and still have cash remaining.

The historical rank and industry rank for Creative Medical Technology Holdings's Cash Ratio or its related term are showing as below:

CELZ' s Cash Ratio Range Over the Past 10 Years
Min: 0.01   Med: 0.28   Max: 26.92
Current: 26.92

During the past 13 years, Creative Medical Technology Holdings's highest Cash Ratio was 26.92. The lowest was 0.01. And the median was 0.28.

CELZ's Cash Ratio is ranked better than
96.46% of 1525 companies
in the Biotechnology industry
Industry Median: 2.95 vs CELZ: 26.92

Creative Medical Technology Holdings Cash Ratio Historical Data

The historical data trend for Creative Medical Technology Holdings's Cash Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Creative Medical Technology Holdings Cash Ratio Chart

Creative Medical Technology Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.01 - 10.21 5.54 26.92

Creative Medical Technology Holdings Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cash Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.54 35.68 34.01 28.44 26.92

Competitive Comparison of Creative Medical Technology Holdings's Cash Ratio

For the Biotechnology subindustry, Creative Medical Technology Holdings's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Creative Medical Technology Holdings's Cash Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Creative Medical Technology Holdings's Cash Ratio distribution charts can be found below:

* The bar in red indicates where Creative Medical Technology Holdings's Cash Ratio falls into.



Creative Medical Technology Holdings Cash Ratio Calculation

The Cash Ratio measures a company's ability to meet its short-term obligations with its cash and near-cash resources.

Creative Medical Technology Holdings's Cash Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash Ratio (A: Dec. 2023 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=9.987/0.371
=26.92

Creative Medical Technology Holdings's Cash Ratio for the quarter that ended in Dec. 2023 is calculated as:

Cash Ratio (Q: Dec. 2023 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=9.987/0.371
=26.92

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Creative Medical Technology Holdings  (NAS:CELZ) Cash Ratio Explanation

The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.

The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.

In general, the higher the cash ratio, the better the company's liquidity position.


Creative Medical Technology Holdings Cash Ratio Related Terms

Thank you for viewing the detailed overview of Creative Medical Technology Holdings's Cash Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Creative Medical Technology Holdings (Creative Medical Technology Holdings) Business Description

Traded in Other Exchanges
N/A
Address
211 E Osborn Road, Phoenix, AZ, USA, 85012
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid-derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.
Executives
Timothy Warbington director, 10 percent owner, officer: President & CEO 211 E. OSBORN ROAD, PHOENIX AZ 85012
Michael H. Finger director 1551 N. DIANE ST., MESA AZ 85203-3850
Susan H Snow director 26 SEDGE FERN DRIVE, HILTON HEAD SC 29926
Bruce Steven Urdang director 5171 E. HAWTHORNE DR., FLAGSTAFF AZ 86004-7377
Thomas Ichim director 211 E. OSBORN RD, PHOENIX AZ 85012
Creative Medical Health Inc. 10 percent owner 211 E. OSBORN RD, PHOENIX AZ 85012
Timothy Herbst 10 percent owner 2031 W. PEORIA AVE., SUITE 250, PHOENIX AZ 85029
Amit Nilkanth Patel director 1040 CHARTWELL CT., SALT LAKE CITY UT 84121
Donald Dickerson director, officer: CFO & Sr.VP 822 VERA STREET, SOLANA BEACH CA 92075
Steven L White director, officer: President,Secretary,Treasurer 386 NORTH 210 EAST, MAPLETON UT 84664

Creative Medical Technology Holdings (Creative Medical Technology Holdings) Headlines

From GuruFocus

Creative Medical Technology Holdings Provides Corporate Update

By PRNewswire PRNewswire 06-12-2023